125 related articles for article (PubMed ID: 23113308)
1. Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation.
Kalinina EV; Berezov TT; Shtil' AA; Chernov NN; Glazunova VA; Novichkova MD; Nurmuradov NK
Bull Exp Biol Med; 2012 Oct; 153(6):878-81. PubMed ID: 23113308
[TBL] [Abstract][Full Text] [Related]
2. The prognostic values of the peroxiredoxins family in ovarian cancer.
Li S; Hu X; Ye M; Zhu X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104402
[No Abstract] [Full Text] [Related]
3. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells.
Goncalves K; Sullivan K; Phelan S
Cancer Invest; 2012 Jan; 30(1):38-47. PubMed ID: 22236188
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes of glutathione transferase isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in tumor cells during the formation of drug resistance to cisplatin.
Kalinina EV; Berozov TT; Shtil AA; Chernov NN; Glasunova VA; Novichkova MD; Nurmuradov NK
Bull Exp Biol Med; 2012 Nov; 154(1):64-7. PubMed ID: 23330092
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells.
Pak JH; Choi WH; Lee HM; Joo WD; Kim JH; Kim YT; Kim YM; Nam JH
Cancer Invest; 2011 Jan; 29(1):21-8. PubMed ID: 21166495
[TBL] [Abstract][Full Text] [Related]
6. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
[TBL] [Abstract][Full Text] [Related]
7. Why does chemotherapy stop affecting the cells of ovarian and breast tumors?
Kalinina EV; Chernov NN
Future Oncol; 2018 May; 14(12):1137-1140. PubMed ID: 29629566
[No Abstract] [Full Text] [Related]
8. siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway.
Duan J; Lang Y; Song C; Xiong J; Wang Y; Yan Y
Mol Med Rep; 2013 May; 7(5):1688-94. PubMed ID: 23503975
[TBL] [Abstract][Full Text] [Related]
9. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.
Wang Z; Cheng Y; Wang N; Wang DM; Li YW; Han F; Shen JG; Yang DP; Guan XY; Chen JP
Cancer Biol Ther; 2012 Feb; 13(3):138-47. PubMed ID: 22231406
[TBL] [Abstract][Full Text] [Related]
10. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.
Ismail T; Kim Y; Lee H; Lee DS; Lee HS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500275
[TBL] [Abstract][Full Text] [Related]
11. Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance.
Kalinina EV; Chernov NN; Saprin AN; Kotova YN; Remizov VI; Shcherbak NP
Bull Exp Biol Med; 2007 Mar; 143(3):328-30. PubMed ID: 18225754
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells.
Jarvis RM; Hughes SM; Ledgerwood EC
Free Radic Biol Med; 2012 Oct; 53(7):1522-30. PubMed ID: 22902630
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity.
McDonald C; Muhlbauer J; Perlmutter G; Taparra K; Phelan SA
Int J Oncol; 2014 Jul; 45(1):219-26. PubMed ID: 24789097
[TBL] [Abstract][Full Text] [Related]
14. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K
Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.
Ummanni R; Barreto F; Venz S; Scharf C; Barett C; Mannsperger HA; Brase JC; Kuner R; Schlomm T; Sauter G; Sültmann H; Korf U; Bokemeyer C; Walther R; Brümmendorf TH; Balabanov S
J Proteome Res; 2012 Apr; 11(4):2452-66. PubMed ID: 22424448
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard.
Tahmasbpour Marzony E; Ghanei M; Panahi Y
Exp Lung Res; 2016 May; 42(4):217-26. PubMed ID: 27266564
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the peroxiredoxin system by cytokines in insulin-producing RINm5F cells: down-regulation of PRDX6 increases susceptibility of beta cells to oxidative stress.
Paula FM; Ferreira SM; Boschero AC; Souza KL
Mol Cell Endocrinol; 2013 Jul; 374(1-2):56-64. PubMed ID: 23623867
[TBL] [Abstract][Full Text] [Related]
18. Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Bajor M; Zych AO; Graczyk-Jarzynka A; Muchowicz A; Firczuk M; Trzeciak L; Gaj P; Domagala A; Siernicka M; Zagozdzon A; Siedlecki P; Kniotek M; O'Leary PC; Golab J; Zagozdzon R
Br J Cancer; 2018 Oct; 119(7):873-884. PubMed ID: 30287919
[TBL] [Abstract][Full Text] [Related]
19. PRDX3 promotes resistance to cisplatin in gastric cancer cells.
Yan H; Cai X; Fu S; Zhang X; Zhang J
J Cancer Res Ther; 2022 Dec; 18(7):1994-2000. PubMed ID: 36647961
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Prdx6 and resistance to peroxide-induced death in Hepa1-6 cells: Prdx suppression increases apoptosis.
Walsh B; Pearl A; Suchy S; Tartaglio J; Visco K; Phelan SA
Redox Rep; 2009; 14(6):275-84. PubMed ID: 20003713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
